Batm Advanced Communicat... Share Discussion Threads

[wizzkid211] 16/12/2021 07:01

BATM Advanced Communications Ld First sales of rapid COVID-19 test in Russia
16/12/2021 7:00am
UK Regulatory (RNS & others)

Batm Advanced Communicat... (LSE:BVC)
Intraday Stock Chart

Thursday 16 December 2021

Click Here for more Batm Advanced Communicat... Charts.
TIDMBVC

RNS Number : 8103V

BATM Advanced Communications Ld

16 December 2021

LEI: 213800FLQUB9J289RU66

16 December 2021

BATM Advanced Communications Limited

("BATM" or "the Group")

First sales of rapid COVID-19 at-home test in Russia

RAPiDgen (R) is the first self-testing COVID-19 test to receive Russian government approval

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has commenced sales of its RAPiDgen SARS-CoV-2 antigen test, which is an easy-to-use rapid test for at-home use, in Russia. It was the first self-testing COVID-19 test to be approved by the Russian public health authorities.

The Group has commenced shipping its first order, worth EUR 250k, which is scheduled to complete in December. The Group expects to receive further orders, of a greater value, in 2022. The test is being sold via pharmacy outlets and ecommerce platforms.

The approval of RAPiDgen for sale followed rigorous testing by the Russian public health authorities and comparison with the polymerase chain reaction ("PCR") tests in use in Russia . RAPiDgen was the first COVID-19 test to be approved for at-home use in Russia and was chosen because of its accuracy and easy-to-use design. It remains one of only three self-testing tests approved for use in Russia and is the only test that has a one-step process with no liquid handling involved.

The RAPiDgen SARS-CoV-2 Ag, which gives results in 10 minutes, uses the lateral flow method. The test has been developed by the Group's Adaltis subsidiary and Gamidor Diagnostics. It is being marketed under the Adaltis brand.

Dr Zvi Marom, CEO of BATM, said: "We are delighted to have received further validation of the high quality of our rapid test when evaluated by teams of experts and compared with PCR tests, which are regarded as the 'gold standard'. We believe our test is the most accurate and easy-to-use test for at-home use in Russia, which represents a substantial market opportunity. The strength of our rapid test is also demonstrated by its use by clients in Israel that have very exacting standards and where early, precise detection of COVID-19 in employees is crucial. We are increasing the production capacity for RAPiDgen, which, in combination with our Adaltis portfolio of other COVID-19 tests, has a vital role to play in managing the pandemic as it continues to evolve."

Further details on the test, including an animated demonstration, can be found here: hxxps://rapidgen.net/

Enquiries:

[fse] 14/12/2021 14:30

The slide in the share price against a plethora of encouraging news was/is hard to fathom. Caught me off guard and I don’t usually get so wrong footed with the movements. At the end of the day BATM is a much larger operation and the valuation in no way reflects this or the value of their IP. Still I have already said all of this and it’s been a frustrating period. I would have thought recent prices would put them on the radar of fund managers.

[paulisi] 14/12/2021 11:57

Sounds promising - all motions were passed.Just annoyed with II that they didn't even send the motions never mind an option to voteNeed these comments from Zvi released into the public domainI'd expect ST to make a comment, it's been a while since his last update.

[doccash] 14/12/2021 10:31

Natlabs should see revenue next year working on collaboration with one of the big boys

[doccash] 14/12/2021 10:30

Zvi commented on gradual share price drop and says it is not understandable

[doccash] 14/12/2021 10:28

Working with UN for great green wall to share agri projects from Celitron in Africa. Sounds like COP was a very good marketing event.

[doccash] 14/12/2021 10:25

Shortage of components has delayed Egility orders but very strong back orders.

[doccash] 14/12/2021 10:06

Dividend looks confirmed from AGM

[paulisi] 12/12/2021 23:14

Not sure - the AGM seems to be a tick box exercise. There will be a limited audience and questions have to be asked in advance.

[paulisi] 10/12/2021 15:40

Absolutely no volume at the moment.I'm expecting a lack of news due to reporting restriction due to AGM timelines and we will get news of further deals and a trading update next week.

[owenski] 09/12/2021 15:06

Not worth buying for a divi, it's just noise afaic. This share took off in 2020 on the back of Covid news, it seems that the ventilators were more of a one off and the share price is deflating back down to those levels or close to again. It's still a long way to the 50 - 60p area.

[jimmywalkden] 09/12/2021 13:51

AGM not until the 14th Dec per the last news release

[paulisi] 09/12/2021 08:53

Gone ex div I believe, but never received any AGM voting details from my broker.

[fse] 07/12/2021 20:35

ARM really should remain independent. It’s a better deal for Telco systems if it does but not a disaster the other way so they say. FWIW.

[rawdeal1] 04/12/2021 09:32

Daily Mail today.... £60bn ARM bid set to collapse.
The deal looks increasingly likely to fall through after the US Federal Trade Commission moved to block the merger ( with Nvidia) on competitive grounds.

[paulisi] 03/12/2021 18:02

Still have the ex div price to kick in next week.

[emeraldzebra] 03/12/2021 12:30

Car1pet - Many apols for my use of the 'c' word - but was only quoting another poster in a jocular way......Of course it has been up to 150p and i think many of us are still scratching our collective heads on what has caused it to lose a very full looking 50 percent of that. But it is easy to overlook that the share price has done very well in the context of a 5 year view - but should be much higher. Patience needed.

[car1pet] 03/12/2021 12:11

I've not been on this board for a while. Language of some posters is not nice.
So the divi is .74p which is 1% that won't stir the buyers into life. I see the price is below 80p. What happened to the 150p this board was predicting?
Same old BATM. Sorry to be boring and repetitive but until they replace Zvi with a commercial head the company will not achieve its potential. All IMO DYOR

[fse] 02/12/2021 15:39

Demands for testing kits has gone through the ever loving roof. I am heading back to Canada from the US and am double vaccinated plus have to have a negative PCR test but that’s not enough as I have to have another test on arriving in Canada and have to isolate until the results come back 3 to 4 days later. Implementation is slow as they can’t buy enough tests. Go figure !

[fse] 01/12/2021 14:27

Certainly can understand the frustration here. You would think they had announced a profit warning rather than a 40% + growth expectation for the coming year which in turn prompted the dividend proposal. I still rate them a strong buy under 120p and that’s allowing for potential disruption from the Omni strain. Adaltis had a test out for this in incredibly rapid order. Hopefully telco tie ups will see remote deployments in spite of troubles getting technicians on site. It does appear that the share price is being manipulated as the lack of conviction and low volumes offer small short positions to have an exaggerated effect. BATM are currently players in some of the highest growth sectors, they are profitable with no debt and sufficient funds to realize their plans all of which is developed “in house” with no dilution to shareholders. I do not know of any company that can make those claims.

[pharmawotsit] 01/12/2021 12:27

 Well, I've had a response from my MP - in under 25 hours.

 Dear,

 Thank you for passing this on. I have asked my Ministerial colleagues to consider your correspondence.

 I will ensure that you receive any correspondence from my Ministerial colleagues in response.

 Yours sincerely,


 Read what you will but it's a much quicker turnaround than the 27 days taken to respond to my previous letter.

 Perhaps we are in less frantic times than we were 9 months ago ?